Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.

CGMP-AA increases blood Phe concentrations and so it can only be used partly to contribute to protein substitute in some children with PKU. CGMP-AA should be carefully introduced in children with PKU and close monitoring of blood Phe control is essential.